. Author manuscript; available in PMC: 2022 Aug 10.

Published in final edited form as: J Perinatol. 2022 Feb 10;42(5):631–635. doi: 10.1038/s41372-022-01333-5

Table 4 –

Developmental Outcomes at Two Years of Age

	High-dose N=19	Standard-dose N=23	P value
Bayley-III Cognitive score	86.1 ± 12.8	88.0 ± 8.4	0.55
Cognitive delay (Mental Development Index < 85), n (%)	6 (32)	5 (22)	0.50
Cognitive impairment (Mental Development Index < 70), n (%)	2 (11)	0	0.20
Bayley-III Composite Language score	92.6 ± 13.7	88.9 ± 11.7	0.36
Language delay (Language Scale score < 85), n (%)	4 (21)	8 (35)	0.49
Language impairment (Language Scale score < 70), n (%)	1	1	1
Bayley-III Composite Motor score	85.7 ± 10.4	85.9 ± 10.4	0.96
Motor delay (Psychomotor Development Index < 85), n (%)	7 (37)	6 (26)	0.38
Motor impairment (Psychomotor Development Index < 70), n (%)	2 (11)	2 (9)	1
Cerebral palsy, n (%)	3 (16)	2 (9)	0.32
Blindness	0	0	N/A
Deafness	0	0	N/A